Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms

Background. Platinum-based chemotherapy is the mainstay of front-line treatment of patients affected by pluri-metastatic intermediate/high grade NeuroEndocrine Neoplasms (NENs). However, there are no standard second-line treatments at disease progression. Previous clinical experiences have evidenced...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Tafuto, Salvatore, von Arx, Claudia, Capozzi, Monica, Tatangelo, Fabiana, Mura, Manuela, Modica, Roberta, Barretta, Maria Luisa, Di Sarno, Antonella, Tornesello, Maria Lina, Colao, Annamaria, Ottaiano, Alessandro
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6723560/
https://ncbi.nlm.nih.gov/pubmed/31443197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8081224
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky